Importance Complete metastatic ablation of oligometastatic prostate cancer may provide an
alternative to early initiation of androgen deprivation therapy (ADT). Objective To determine …

The authors define molecular imaging, according to the Society of Nuclear Medicine and
Molecular Imaging, as the visualization, characterization, and measurement of biological …

Purpose Prostate-specific membrane antigen (PSMA) is a recognized target for imaging
prostate cancer. Here we present initial safety, biodistribution, and radiation dosimetry results …

… MJ Morris and SP Rowe contributed equally to this article. … SP Rowe reports grants from
Progenics Pharmaceuticals during the conduct of the study, as well as personal fees from …

Rationale The development of consensus guidelines for interpretation of Prostate-Specific
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide more …

Purpose: Prostate specific membrane antigen-targeted positron emission tomography/computerized
tomography has the potential to improve the detection and localization of prostate …

Context Prostate-specific membrane antigen (PSMA) targeting positron emission tomography
(PET) is emerging to become a reference imaging tool for the staging and restaging of …

Purpose Current standard of care conventional imaging modalities (CIM) such as X-ray
computed tomography (CT) and bone scan can be limited for detection of metastatic prostate …

Background The rapidly expanding clinical adaptation of prostate-specific membrane
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …

We previously demonstrated the ability to detect metastatic prostate cancer using N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-
18 F-fluorobenzyl-l-cysteine ( 18 F-DCFBC), a low-…